Photo of { David B. Haslam, MD}

David B. Haslam, MD


  • Director, Antimicrobial Stewardship Program
  • Director, Microbial Genomics and Metagenomics Laboratory
  • Professor, UC Department of Pediatrics
I work with my patients and their families as a team and feel that taking care of children is a wonderful privilege and a responsibility.
David B. Haslam, MD

About

Biography

I was influenced by my father, who was a pediatrician and took great satisfaction in caring for children. As a pediatric infectious disease specialist, I work with my patients and their families as a team and feel that taking care of children is a wonderful privilege and a responsibility.

In my practice, I try to be flexible by coordinating my patients' appointments with those of other providers when possible. I'm committed to providing continuity and to being accessible between visits.

I'm the director of the Antimicrobial Stewardship Program and the Microbial Genomics and Metagenomics Laboratory. I've received several teaching and research awards, including the Pediatric Infectious Disease Society Young Investigator Award.

The main focus of my research is on the microbiome, which is the community of bacteria, viruses, fungi and other organisms that live on the human body. The goal is to understand how the microbiome influences disease and contributes to health in children. A healthy microbiome helps protect against infection, allergy, gastrointestinal diseases, heart disease, diabetes and diseases of premature infants.

In my free time, I enjoy riding my bike.

MD: University of Calgary, Calgary, Alberta

Internship: McGill University, Montreal, Quebec

Residency: University of Ottawa, Ottawa, Quebec

Fellowship: Washington University School of Medicine, St. Louis, MO

Insurance Information

Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.

View Insurance Information

Publications

Aging of the adaptive immune system affects the gut microbiome and systemic levels of vitamin B6. Stahl, S; Widmaier, H; Sakk, V; Nalapareddy, K; Kissmann, A-K; Rosenau, F; Mulaw, MA; Haslam, DB; Geiger, H. Microbiome. 2026; 14(1).

Learning immunology from mothers and babies. Turner, LH; Sun, J; Brady, AE; Adhikari, U; Nguyen, NNM; Mercado, MAB; Ando, S; Diep, RE; Pham, G; Madabhushi, M; Haslam, DB; Araki, K; Way, SS. Mucosal Immunology. 2026; 100353.

The gut virome in children undergoing hematopoietic cell transplantation is diverse and a site for viral reactivation. Khandelwal, P; Haslam, D; Ibrahimova, A; Laskin, B; Webster, A; Blackard, JT; Lake, K; Hoerth, C; Luebbering, N; Abdullah, S; Davies, SM. Bone Marrow Transplantation. 2026.

Candidalysin promotes fungal-specific Th17 CD4 T cell differentiation and protective systemic immunogenicity. Nguyen, NNM; Brady, AE; Haslam, DB; Frazer, C; Pham, G; Bennett, RJ; Way, SS. Mucosal Immunology. 2026; 100348.

Natural maternal immunity protects neonates from Escherichia coli sepsis. Diep, RE; Adhikari, U; Gokce Tezel, K; Pham, G; Burrell, AR; Staat, MA; Nhu, NTK; Phan, M-D; Peters, KM; Schembri, MA; Saunders, SH; Haslam, DB; Erickson, JJ; Chavez-Bueno, S; Way, SS. Nature. 2026; 653(8114):519-527.

Clostridioides difficile Colonization and Infection in Pediatric Oncology and Stem Cell Transplant Patients. Willis, DN; Dubberke, ER; Hayashi, RJ; Tarr, PI; Haslam, DB; Hink, T; Luo, J; Tao, Y; Padhye, A; Hall, EM; Storch, GA. Open Forum Infectious Diseases. 2026; 13(4):ofag149.

Clinical Care Practices Shape Microbiome-Associated Bloodstream Infection Risk in Geographically Distinct NICUs. Xu, Y; Akinbi, H; Shen, Z; Zhu, J; Shi, L; Du, L; Haslam, DB. Clinical Infectious Diseases. 2026.

Azithromycin use for common acute respiratory infections during a Mycoplasma pneumoniae national surge: results from the SHARPS-OP benchmarking collaborative. El Feghaly, RE; Kronman, MP; Smith, MJ; Patel, SJ; Olivero, R; Herigon, J; Wirtz, A; Lee, BR. Infection Control and Hospital Epidemiology. 2026; 1-3.

Microbiota from young mice restore the function of aged ISCs. Nalapareddy, K; Haslam, DB; Kissmann, A-K; Alenghat, T; Stahl, S; Rosenau, F; Zheng, Y; Geiger, H. Stem Cell Reports. 2026; 21(2):102788.

2’-Fucosyllactose (Human Milk Oligosaccharide) Reduces Dysbiosis and Acute GI GVHD in Children and Young Adults Following HSCT: A Prospective, Single-Center Phase II Study. Ramos, KN; Langenberg, L; Lake, KE; Hoerth, C; Luebbering, N; Haslam, D; Newburg, D; Morrow, AL; Ollberding, NJ; Teusink, A; Watanabe-Chailland, M; Romick-Rosendale, L; Davies, SM; Khandelwal, P. Transplantation and Cellular Therapy. 2026; 32(2):s570.

From the Blog

Replacing Microbiota Makes Aging Intestines Young Again
Digestive System

Replacing Microbiota Makes Aging Intestines Young Again

David B. Haslam, MD, Theresa Alenghat, VMD, PhD ...1/22/2026

Antibiotics Are Not Always the Answer
Blog Healthy Living

Antibiotics Are Not Always the Answer

By David B. Haslam, MD11/8/2023

Patient Ratings and Comments

All patient satisfaction ratings and comments are submitted by actual patients and verified by a leading independent experience management company, Qualtrics. Patient identities are withheld to ensure confidentiality and privacy. Only those providers whose satisfaction surveys are administered through Cincinnati Children’s Hospital Medical Center are displayed. Click here to learn more about our survey

Loading ...
Loading ...